Experts say expanding eligibility requires a delicate balance of prioritizing those most at risk and ensuring no dose goes to waste.
The 11-month-old app has exploded in popularity, even as it grapples with harassment, misinformation and privacy issues.
Experts say expanding eligibility requires a delicate balance of prioritizing those most at risk and ensuring no dose goes to waste.